Metyrapone single administration, as a possible predictive tool of its dosage and timing in Cushing’s syndrome

Metyrapone single administration, as a possible predictive tool of its dosage and timing in Cushing’s syndrome

Metyrapone is commonly used in the initial management of Cushing’s syndrome to reduce hypercortisolemia, but its optimal dosage and timing can vary significantly between patients. Currently, there are limited guidelines on adjustment methods for its administration to individual needs. This study aim...

Full description

Saved in:
Bibliographic Details
Main Authors: Yasutaka Tsujimoto, Naoki Yamamoto, Hironori Bando, Masaaki Yamamoto, Yuka Ohmachi, Yuma Motomura, Yuka Oi-Yo, Yuriko Sasaki, Masaki Suzuki, Shin Urai, Michiko Takahashi, Genzo Iguchi, Wataru Ogawa, Hidenori Fukuoka
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-12-01
Series:Frontiers in Endocrinology
Subjects:
Cushing’s syndrome
Cushing’s disease
metyrapone
hypercortisolemia
drug responsiveness
monitoring marker
Online Access:https://www.frontiersin.org/articles/10.3389/fendo.2024.1511155/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.frontiersin.org/articles/10.3389/fendo.2024.1511155/full

Similar Items